Healthy volunteers test new drug orialpha for safety first
NCT ID NCT07300202
First seen Jan 03, 2026 · Last updated May 22, 2026 · Updated 25 times
Summary
This early-stage study tested the safety of a new drug called Orialpha (BD-C) in 15 healthy adults aged 18 to 60. Researchers gave increasing doses to find the highest safe amount and watched for side effects. The goal was not to treat any disease, but to gather safety information for future studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hanoi Medical University
Hanoi, Hanoi, 100000, Vietnam
Conditions
Explore the condition pages connected to this study.